Navigation Links
Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
Date:10/16/2007

CHICAGO, Oct. 16 /PRNewswire/ -- The Preimplantation Genetic Diagnosis International Society (PGDIS) is releasing a statement in response to a Practice Committee Opinion issued today by the American Society for Reproductive Medicine (ASRM).

The rationale for determining chromosomal status in transferring normal embryos is unassailable. More than 50% of embryos created in the lab from In Vitro Fertilization (IVF) are genetically abnormal - this is the de novo. However, the practice committee of ASRM has released an opinion statement regarding the practice of this screening approach during IVF.

Although the desired randomized trials have not been possible in North America because of lack of governmental funding, careful analysis and abundant data support that in experienced hands preimplantation genetic screening (PGS) is unequivocally beneficial in patients suffering from translocations, repeated spontaneous abortions, and often in advanced maternal age.

It is the opinion of PGDIS as the organization consisting of international experts in this field (embryologists, geneticists and reproductive endocrinologists) that the ASRM opinions have taken into consideration neither contemporary literature nor facts that could have been provided by embryologists, geneticists and laboratories responsible for over 90 percent of these tests worldwide.

A beneficial effect requires experienced embryologists and geneticists who can obtain blastomeres and analyze single cells in optimal fashion. Considerable expertise is required.

"Couples should be informed that this is a valuable test in selected cases," says Joe Leigh Simpson, MD and President of PGDIS. "This is however a demanding test. There are only about 15-20 centers in the US that have sufficient expertise to perform this test. Patients should be referred to these highly experienced centers."

PGDIS has an active educational program and offers workshops to train scientists in the requisite techniques. For more information on PGDIS, go to http://www.pgdis.org. PGDIS holds open international meetings, the next one which is April 25-27 in Barcelona, Spain.

About PGDIS:

PGDIS coordinates research, education and training in preimplantation genetic diagnosis (PGD), requiring a close collaboration of obstetricians, fertility specialists, embryologists and human geneticists, to insure safety and accuracy of PGD and its application into clinical practice for improvement of genetic practices and reproductive medicine.

PGDIS was organized in October 2002 and inaugurated during the 5th International Symposium on Preimplantation Genetics, Antalya, Turkey, June 5-7, 2003.

Founding Members of PGDIS are the participants of the 4th International Symposium on Preimplantation Genetics, Limassol, Cyprus, 2002; and 5th International Symposium on Preimplantation Genetics, Antalia, Turkey, 2003.

The official Journal of PGDIS is Reproductive BioMedicine Online, which has recently published many papers in this field.


'/>"/>
SOURCE The Preimplantation Genetic Diagnosis InternationalSociety (PGDIS)
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
3. Genetics Journal Thimerosal/Autism Study the Best Science Drug Company Money Can Buy
4. Targeted Genetics Reports Inflammatory Arthritis Clinical Data at European Rheumatology Conference
5. Myriad Genetics Presents Mathematical Comparison of Disease Modification Trial Designs at Alzheimers ConferenceCurrent Flurizan Phase 3 Study Design May Demonstrate Disease Modification
6. Vion Pharmaceuticals Presents Clinical Data from a Phase II Trial of Cloretazine (VNP40101M) in Elderly AML Patients with Unfavorable Cytogenetics at EHA Meeting
7. ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial in B-Cell Chronic Lymphocytic Leukemia
8. Researchers Identify New Genetic Risk Factors for Type 2 Diabetes
9. Targeting Specific Mutations Reveals Promising New Approach to Treating Genetic Disorders; Preclinical Data Published in Nature
10. Myriad Genetics Presents Tumor Origin Technology at AACR
11. Seattle Genetics Highlights Data on its Proprietary Antibody-Drug Conjugate Technology at AACR
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... 2017   Spectrum Pharmacy Products , a division ... exhibiting at the Educational Conference, February 22-25, 2017, in ... Coronado Bay Resort. Spectrum will be showcasing its new ... . The annual Educational Conference is presented by the ... Compounding Pharmacists (IACP) and the American College of Veterinary ...
(Date:2/20/2017)... 20, 2017  This report analyzes the worldwide markets for ... The report provides separate comprehensive analytics for the US, ... , Europe , Asia-Pacific ... Rest of World. Read the full ... forecasts are provided for the period 2015 through 2022. ...
(Date:2/20/2017)... , Feb. 20, 2017  National Decision Support ... integrate the company,s CareSelect Imaging platform within the ... agreement sets the technical foundation for MEDITECH sites, ... CareSelect Imaging Clinical Decision Support Mechanism through the ... directly with and support the integration of NDSC,s ...
Breaking Medicine Technology:
(Date:2/20/2017)... ... 2017 , ... Nancy Johnston Toll marks her debut in the ... the Bump in the Road ” (published by Xlibris). Inspired from her personal experiences, ... the ups and downs experienced by anyone going through cancer treatment and how one ...
(Date:2/20/2017)... ... 2017 , ... Silverado today is pleased to announce that it has entered ... care community in Alexandria, Virginia. The new community is expected to open its doors ... , The three-story community with underground parking – located on King Street –will ...
(Date:2/20/2017)... Orlando, FL (PRWEB) , ... February 20, 2017 ... ... Director, beth[at]orbitahealth[dot]com, +1 (414) 213-8818 , Orbita, Inc., a leading provider of innovative ... software-as-a-service solution for increasing patient engagement and optimizing care journey management for home ...
(Date:2/20/2017)... , ... February 20, 2017 , ... ... check-in, a cloud-based self-service technology that runs on the Posiflex XT-series of touch ... 1076 during HIMSS17 in Orlando, Florida. The terminal provider Posiflex is ...
(Date:2/20/2017)... ... February 20, 2017 , ... ... announced Biscom Document Router (BDR), the first IoT device from Biscom designed to ... imaging. Biscom will debut BDR at HIMSS17 and will be conducting ...
Breaking Medicine News(10 mins):